Displaying 81 - 100 of 1535
Easy Healthcare Corporation, U.S. v.
The FTC reached a settlement with the developer of the fertility app Premom over allegations it deceived users by sharing their sensitive personal information with third parties, including two China-based firms, disclosed users’ sensitive health data to AppsFlyer and Google, and failed to notify consumers of these unauthorized disclosures in violation of the Health Breach Notification Rule (HBNR).
FTC Files Amicus Brief in Bystolic Antitrust Litigation Supporting Competition in the Hypertension Drug Market
FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law
16 CFR Part 318: Health Breach Notification Rule (NPRM)
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule
Ovulation Tracking App Premom Will be Barred from Sharing Health Data for Advertising Under Proposed FTC Order
FTC Deepens Inquiry into Prescription Drug Middlemen
Amgen Inc. and Horizon Therapeutics plc, FTC v.
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
FTC Releases Agenda for May 18 Workshop on Proposed Changes to the Eyeglass Rule
FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law
FTC Sends 37 New Cease and Desist Letters Regarding Agency’s Eyeglass Rule
Displaying 81 - 100 of 1535